XENOPORT INC (XNPT) Downgraded by Zacks to NEUTRAL

Zacks Zacks Investment Research downgraded shares of XENOPORT INC (XNPT) from OUTPERFORM to NEUTRAL on September 14, 2012, with a target price of $11.20.

XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of existing drugs.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

To get a free copy of the research report on XENOPORT INC (XNPT),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .

Be the first to comment

Leave a Reply